The impact of comorbidities in patients with spondyloarthritis
Int J Rheum Dis
.
2023 Jul;26(7):1222-1224.
doi: 10.1111/1756-185X.14682.
Authors
Xiujuan Hou
1
,
Yung-Heng Lee
2
3
4
5
,
Tangliang Qian
1
,
Connie Chen
6
7
,
Lai-Shan Tam
8
Affiliations
1
Department of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
2
Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
3
Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan.
4
Department of Senior Services Industry Management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
5
Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
6
Department of Optometry, Chung Shan Medical University, Taichung, 40201, Taiwan.
7
Institute of Optometry, Chung Shan Medical University, Taichung, 40201, Taiwan.
8
Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
PMID:
37394891
DOI:
10.1111/1756-185X.14682
No abstract available
Publication types
Editorial
MeSH terms
Comorbidity
Humans
Spondylarthritis* / diagnosis
Spondylarthritis* / epidemiology